Latest Content

Cefdinir is linked to nearly double the outpatient uncomplicated UTI treatment failure of cephalexin, with higher recurrence and increased resistance to other cephalosporins.

The author, from Reimagine Care, discusses how AI can enhance oncology care by prioritizing patient needs, fostering trust, and streamlining communication through familiar text-based support for all ages.

AI is poised to transform oncology with innovative tools enhancing diagnosis, treatment, and clinical trials, despite some wariness from clinicians and patients.

A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment landscape for relapsed/refractory multiple myeloma, focusing on the challenges of bringing bispecific antibodies to patients in an outpatient setting.

Utilizing the Health Insurance Disparities Index for assessment, the authors found that New York’s Medicaid health maintenance organizations (HMOs) outperformed Medicaid HMOs nationally in addressing health care disparities from 2019 to 2023.

HHS has initiated removal of black box warnings on hormone replacement therapy, citing its advantages to women's health, but also drawing pushback.

The trial did not meet its primary end point for reducing plaque progression.

New findings reveal high rates of depression, anxiety, and sleep issues in individuals with psoriatic arthritis and palmoplantar psoriasis.

In this investigation, the authors evaluated the impact of a voluntary transition to risk-based contracts under Medicare Advantage on health care use.